| Dana Perry, FNP-C | |
|
601 E 7th St, Platte, SD 57369-2123 | |
| (605) 337-1501 | |
| (605) 337-3360 |
| Full Name | Dana Perry |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 601 E 7th St, Platte, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962129189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP002559 (South Dakota) | Primary |
| Entity Name | Platte Community Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629072400 PECOS PAC ID: 6507770054 Enrollment ID: O20061018000130 |
News Archive
The Academy for Eating Disorders (AED), a global professional association committed to leadership in eating disorders research, education, treatment and prevention, issued guidelines for childhood obesity prevention programs to ensure that community- and school-based efforts are carried out with equal concern for children's physical, social and emotional health.
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases, an institute within the National Institutes of Health, for advanced development of the company's third generation anthrax vaccine candidate.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.
› Verified 7 days ago
| Entity Name | Platte Community Memorial Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1235133109 PECOS PAC ID: 6507770054 Enrollment ID: O20101018000651 |
News Archive
The Academy for Eating Disorders (AED), a global professional association committed to leadership in eating disorders research, education, treatment and prevention, issued guidelines for childhood obesity prevention programs to ensure that community- and school-based efforts are carried out with equal concern for children's physical, social and emotional health.
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases, an institute within the National Institutes of Health, for advanced development of the company's third generation anthrax vaccine candidate.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dana Perry, FNP-C 702 Main Ave, Geddes, SD 57342-2201 Ph: (605) 680-7223 | Dana Perry, FNP-C 601 E 7th St, Platte, SD 57369-2123 Ph: (605) 337-1501 |
News Archive
The Academy for Eating Disorders (AED), a global professional association committed to leadership in eating disorders research, education, treatment and prevention, issued guidelines for childhood obesity prevention programs to ensure that community- and school-based efforts are carried out with equal concern for children's physical, social and emotional health.
Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases, an institute within the National Institutes of Health, for advanced development of the company's third generation anthrax vaccine candidate.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance to the Focus Diagnostics Simplexa Flu A/B & RSV test on the 3M™ Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is intended as an aid in the detection and discrimination of influenza A, influenza B and RSV virus infections.
The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.
› Verified 7 days ago
April Marie Veurink, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 E 7th St, Platte, SD 57369 Phone: 605-337-3364 | |
Stephanie Leader, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 E 7th St, Platte, SD 57369 Phone: 605-337-1503 Fax: 605-337-3360 |